USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
CELLASIC CORPORATION
Address:
2544 Barrington Court
Hayward, CA
Phone:
N/A
URL:
N/A
EIN:
201655470
DUNS:
171076743
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,441,758.00 5
SBIR Phase II $3,182,172.00 4

Award List:

Microfluidic System for Automated Cell Toxicity Screening

Award Year / Program / Phase:
2006 / SBIR / Phase I
Award Amount:
$105,000.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The main objective of this proposal is to develop a microfluidic platform for cancer drug toxicity screening in cultured human cells. While it is believed that improved information on a patient's individual cancer signature can aid diagnosis and treatment, the… More

Microfluidic Bioreactor for High Throughput Cell-based

Award Year / Program / Phase:
2006 / SBIR / Phase I
Award Amount:
$199,700.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The grant application proposes the development of an SBS standard thermoplastic (PMMA) microfluidic bioreactor for high throughput continuously perfused cell-based screening for the pharmaceutical and biotechnology industry. More specifically, the 1- year Phase I… More

Continuous Perfusion Cell Microarray for In Vitro Toxicity Screening

Award Year / Program / Phase:
2006 / SBIR / Phase I
Award Amount:
$135,250.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The main objective of this proposal is to develop and deliver a high density continuous perfusion cell microarray to enable high throughput and high quality cell-based screening for the pharmaceutical and biotechnology industry. More specifically, the 6-month… More

Microfluidic Cell Culture Array for Predictive Toxicity Screening

Award Year / Program / Phase:
2007 / SBIR / Phase II
Award Amount:
$800,039.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The main objective of the Phase II proposal is to further develop the microfluidic cell culture array for high quality cell-based life science applications in the pharmaceutical and biotechnology industry. This will foc us on predictive hepatotoxicity screening,… More

Microfluidic Bioreactor for High Throughput Hepatotoxicity Screening

Award Year / Program / Phase:
2008 / SBIR / Phase II
Award Amount:
$684,258.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The main objective of the Phase II proposal is to commercialize the SBS standard format microfluidic bioreactor array developed in Phase I for high throughput physiologic cell-based screening in the pharmaceutical and b iotechnology industry, with special focus… More

Microfluidic Platform for Cancer Cell Culture and Analysis

Award Year / Program / Phase:
2008 / SBIR / Phase II
Award Amount:
$897,100.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): This Phase II SBIR proposes to develop a microfluidic cell culture and analysis platform for the in vitro screening of cancer cells. The end result of this research will be to deliver a fully functional system (automate d instrument and disposable microfluidics)… More

Microfluidic Liver Array for Drug Metabolite Profiling

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$896,600.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): CellASIC has developed a novel microfluidic technology to integrate 32 bioreactors on a standard 96-well plate for multiplexed perfusion culture of primary human hepatocytes with demonstrated long-term viability and li ver-enzymatic function. This Phase 1 SBIR… More

Microfluidic Liver Array for Long Term In Vitro Hepatocyte Culture and Screening

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$105,208.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The goal of this proposal is to complete development of a Microfluidic Liver Array (MLA) platform for improved and lower cost in vitro toxicity screening targeting the human liver. This funding will directly lead to the commercialization of a product with … More

Microfluidic Liver Array for Long Term In Vitro Hepatocyte Culture and Screening

Award Year / Program / Phase:
2011 / SBIR / Phase II
Award Amount:
$800,775.00
Agency:
HHS
Principal Investigator:
Philip J. Lee – 510-785-9846
Abstract:
DESCRIPTION (provided by applicant): The goal of this proposal is to complete development of a Microfluidic Liver Array (MLA) platform for improved and lower cost in vitro toxicity screening targeting the human liver. This funding will directly lead tothe commercialization of a product with … More